Citizens
NYSE:CIACitizens, Inc. provides life insurance products in the United States and internationally. The company operates in two segments, Life Insurance and Home Service Insurance. The Life Insurance segment issues ordinary whole life insurance and endowment policies in the United States dollar-denominated amounts to non-U.S. residents in through independent marketing agencies and consultants. The Home Service Insurance segment offers final expense life insurance and property insurance policies to middle-and lower-income households, as well as whole life products in Louisiana, Mississippi, and Arkansas. This segment provides its products and services through funeral homes and independent agents. The company provides accident and health insurance policies. Citizens, Inc. was founded in 1969 and is headquartered in Austin, Texas.
Hunter Technology
CVE:HOCHunter Technology Corp. focuses on the development, operation, and management of digital platforms for energy resources in Canada. It offers OilEx, a blockchain-based marketplace for hydrocarbons that enables international buyers of physical oil to connect with independent crude oil producers in a global market. The company also provides OilExchange, a supply chain intelligence service that provides a full suite of data collection, monitoring, and analytics functions enabling a real-time view along the physical oil trading supply chain. Hunter Technology Corp. has a strategic partnership with WellDatabase that allows the company to integrate with WellDatabase's operational E&P data from across the United States and Canada. The company was formerly known as Hunter Oil Corp. and changed its name to Hunter Technology Corp. in November 2020. Hunter Technology Corp. was incorporated in 1980 and is headquartered in Vancouver, Canada.
Metagenomi
NASDAQ:MGXMetagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a strategic collaboration and license agreement with ModernaTX, Inc. focusing on new genome editing system for in vivo human therapeutic applications; a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California.